U
MDXG icon

UBS’s MiMedx Group MDXG Stock Holding History

UBS’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Hold
500
– – ﹤0.01% 9622
2014
Q2 		$4K Buy
+500
New +$2.93K ﹤0.01% 9675
2014
Q1 		– Sell
-1,100
Closed -$10K – 10631
2013
Q4 		$10K Buy
+1,100
New +$6.74K ﹤0.01% 8979

Other funds holding MDXG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS's MDXG Position: Q3 2014 in Review

UBS held its MiMedx Group (MDXG) position steady in Q3 2014 at 7,825 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #6686.

UBS first reported a position in MDXG in Q2 2013 and has held it in 6 quarters since. The position peaked at $127K in Q2 2013. 125 funds tracked by Wall St. Rank hold MDXG as of Q3 2014.

  • UBS held 7,825 shares of MiMedx Group worth $56K as of Q3 2014.
  • UBS left its MiMedx Group share count unchanged in Q3 2014.
  • MiMedx Group made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6686 holding.
  • UBS first reported a position in MiMedx Group in Q2 2013 and has held it in 6 quarters since.
  • UBS's MiMedx Group position peaked at $127K in Q2 2013.
  • 125 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.